Search research articles
Contact Us
Filters
Showing results (371-380 of 536) with videos related to
Page
of 54
Sort By:
Blood Advances
|
July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
Alison R Walker, Guido Marcucci, Jun Yin, et al.
The Journal of Experimental Medicine
|
April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine
|
January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine
|
June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Clinical Investigation
|
August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Cancer Medicine
|
April 21, 2023
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience
Idoroenyi Amanam, Janny Yao, Alfredo Puing, et al.
Blood Advances
|
February 5, 2025
Targeting RNA modification and mitochondrial metabolism cross talk in leukemic stem cells with CDK7 inhibitor TGN-1062
Hyunjun Kang, Lianjun Zhang, Mohan R Kaadige, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2008
Prevention and treatment of cancer-related infections
Brahm H Segal, Alison G Freifeld, Lindsey Robert Baden, et al.
Cancers
|
December 17, 2024
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)
Hoda Pourhassan, Tina Nguyen, Dongyun Yang, et al.
Transplantation and Cellular Therapy
|
November 12, 2023
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Hany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Page
of 54
Search research articles
Search
Showing results (371-380 of 536) with videos related to
Sort By:
Page
of 54
Blood Advances
|
July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
Alison R Walker, Guido Marcucci, Jun Yin, et al.
The Journal of Experimental Medicine
|
April 24, 2013
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine
|
January 21, 2017
Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Experimental Medicine
|
June 30, 2026
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri, Dario Palmieri, Luciana De Luca, et al.
The Journal of Clinical Investigation
|
August 25, 2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
Paolo Neviani, Ramasamy Santhanam, Joshua J Oaks, et al.
Cancer Medicine
|
April 21, 2023
Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience
Idoroenyi Amanam, Janny Yao, Alfredo Puing, et al.
Blood Advances
|
February 5, 2025
Targeting RNA modification and mitochondrial metabolism cross talk in leukemic stem cells with CDK7 inhibitor TGN-1062
Hyunjun Kang, Lianjun Zhang, Mohan R Kaadige, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2008
Prevention and treatment of cancer-related infections
Brahm H Segal, Alison G Freifeld, Lindsey Robert Baden, et al.
Cancers
|
December 17, 2024
Combined Cytokine Blockade Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft-Versus-Host Disease (SR-GvHD)
Hoda Pourhassan, Tina Nguyen, Dongyun Yang, et al.
Transplantation and Cellular Therapy
|
November 12, 2023
Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
Hany Elmariah, Salman Otoukesh, Ambuj Kumar, et al.
Page
of 54